AMEDISYS INC (AMED)

US0234361089 - Common Stock

90.16  +0.16 (+0.18%)

After market: 90.16 0 (0%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

AMEDISYS INC

NASDAQ:AMED (11/21/2024, 8:12:03 PM)

After market: 90.16 0 (0%)

90.16

+0.16 (+0.18%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Providers & Services
GICS SubIndustry
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%
Sales Q2Q%
CRS
6 Month-6.31%
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap2.95B
Shares
PE21.02
Fwd PE17.38
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

AMED Daily chart

Company Profile

Amedisys, Inc. engages in the provision of healthcare services. The company is headquartered in Baton Rouge, Louisiana and currently employs 19,000 full-time employees. The firm is engaged in providing care and support in the home. The company delivers clinically distinct care that suits its patients' needs, whether that is home-based recovery and rehabilitation after an operation or injury or care. Its operations involve serving patients across the United States through its three operating divisions: home health, hospice, and high acuity care. Its home health segment provides compassionate healthcare to help its patients recover from surgery or illness, live with chronic diseases, and prevent avoidable hospital readmissions. The home health includes 346 care centers located in 34 states within the United States and the District of Columbia. Its hospice care is designed to provide comfort and support for those who are dealing with a terminal illness. Its high acuity care segment delivers the essential elements of inpatient hospital, skilled nursing facility care and palliative care to patients in their homes.

Company Info

AMEDISYS INC

3854 American Way Ste A, 5959 S Sherwood Forest Blvd

Baton Rouge LOUISIANA 70816

P: 12252922031

CEO: Paul B. Kusserow

Employees: 19000

Website: https://www.amedisys.com/

AMED News

News Image8 days ago - Market News VideoNotable Wednesday Option Activity: X, AMED, GAP
News Image10 days ago - Market News VideoInteresting AMED Put And Call Options For December 2025
News Image10 days ago - BloombergUS Justice Department Preps Suit Over UnitedHealth-Amedisys Deal

The US Justice Department is moving to block UnitedHealth Group Inc.’s $3.3 billion purchase of Amedisys Inc. over concerns the deal would harm competition in the market for home-health services, according to people familiar with the matter.

News Image15 days ago - Amedisys, Inc.Amedisys Reports Third Quarter 2024 Financial Results

BATON ROUGE, La., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and nine-month...

News Image21 days ago - Market News VideoAmedisys is Now Oversold (AMED)
News Imagea month ago - BloombergUnitedHealth to Make Last Push for DOJ Blessing on Amedisys Deal

UnitedHealth Group Inc. and Amedisys Inc. representatives are slated to meet with top Justice Department antitrust enforcers next week in a last-ditch effort to persuade the agency not to challenge their proposed tie-up, according to people familiar with the matter.

AMED Twits

Here you can normally see the latest stock twits on AMED, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example